NCT00859547View on ClinicalTrials.gov

Safety and Immunogenicity Study of Recombinant Thrombin (rThrombin) in Pediatric Participants

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Blood Loss, Surgical
Interventions
BIOLOGICAL

rThrombin, 1000 IU/mL

rThrombin,1000 IU/mL, 1000 IU/mL, applied topically to the bleeding site during a single surgery procedure on Day 1.

Trial Locations (1)

85008

Arizona Burn Center, Phoenix

Sponsors

Lead Sponsor

ZymoGenetics
All Listed Sponsors
lead

ZymoGenetics

INDUSTRY

NCT00859547 - Safety and Immunogenicity Study of Recombinant Thrombin (rThrombin) in Pediatric Participants | Biotech Hunter | Biotech Hunter